O. K. Sirin Et Al. , "PPAR gamma Pro 12Ala and C161T polymorphisms, but not PPAR alpha L162V, are associated with osteoporosis risk in Turkish postmenopausal women," ISTANBUL JOURNAL OF PHARMACY , vol.49, no.1, pp.14-19, 2019
Sirin, O. K. Et Al. 2019. PPAR gamma Pro 12Ala and C161T polymorphisms, but not PPAR alpha L162V, are associated with osteoporosis risk in Turkish postmenopausal women. ISTANBUL JOURNAL OF PHARMACY , vol.49, no.1 , 14-19.
Sirin, O. K., Aydogan, H. Y., Uyar, M., & Can, A., (2019). PPAR gamma Pro 12Ala and C161T polymorphisms, but not PPAR alpha L162V, are associated with osteoporosis risk in Turkish postmenopausal women. ISTANBUL JOURNAL OF PHARMACY , vol.49, no.1, 14-19.
Sirin, Ozlem Et Al. "PPAR gamma Pro 12Ala and C161T polymorphisms, but not PPAR alpha L162V, are associated with osteoporosis risk in Turkish postmenopausal women," ISTANBUL JOURNAL OF PHARMACY , vol.49, no.1, 14-19, 2019
Sirin, Ozlem K. Et Al. "PPAR gamma Pro 12Ala and C161T polymorphisms, but not PPAR alpha L162V, are associated with osteoporosis risk in Turkish postmenopausal women." ISTANBUL JOURNAL OF PHARMACY , vol.49, no.1, pp.14-19, 2019
Sirin, O. K. Et Al. (2019) . "PPAR gamma Pro 12Ala and C161T polymorphisms, but not PPAR alpha L162V, are associated with osteoporosis risk in Turkish postmenopausal women." ISTANBUL JOURNAL OF PHARMACY , vol.49, no.1, pp.14-19.
@article{article, author={Ozlem Kurt Sirin Et Al. }, title={PPAR gamma Pro 12Ala and C161T polymorphisms, but not PPAR alpha L162V, are associated with osteoporosis risk in Turkish postmenopausal women}, journal={ISTANBUL JOURNAL OF PHARMACY}, year=2019, pages={14-19} }